Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
252.93
-3.10 (-1.21%)
At close: Oct 5, 2026, 4:00 PM EDT
253.02
+0.09 (0.04%)
After-hours: Oct 5, 2026, 6:25 PM EDT
Johnson & Johnson Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 28, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Revenue Revenue Growth | 25,310 | 24,062 | 24,564 | 23,993 | 23,743 | 21,893 | 22,520 | 22,471 | 22,447 | 21,383 | 21,395 | 21,351 | 21,519 | 20,894 | - | 19,996 | - | 23,426 | 24,804 | 23,338 |
Revenue Growth | 6.60% | 9.91% | 9.08% | 6.77% | 5.77% | 2.38% | 5.26% | 5.25% | 4.31% | 2.34% | - | 6.78% | - | -10.81% | - | -14.32% | - | 4.95% | 10.36% | 10.70% |
Gross Profit Gross Profit Growth | 17,294 | 15,976 | 16,752 | 16,702 | 16,130 | 14,544 | 15,612 | 15,714 | 15,580 | 14,879 | 14,880 | 14,971 | 15,057 | 14,407 | - | 13,824 | - | 15,828 | 16,784 | 16,106 |
Operating Income Operating Income Growth | 7,388 | 6,595 | 5,887 | 7,246 | 6,862 | 6,338 | 4,088 | 5,509 | 6,515 | 6,310 | 4,836 | 6,381 | 6,318 | 6,399 | - | 5,651 | - | 6,728 | 5,059 | 6,836 |
Net Income Net Income Growth | 5,534 | 5,235 | 5,116 | 5,152 | 5,537 | 10,999 | 3,431 | 2,694 | 4,686 | 3,255 | 4,049 | 26,028 | 5,144 | -68 | - | 4,458 | - | 5,149 | 4,736 | 3,667 |
Earnings Per Share EPS Growth | 2.27 | 2.14 | 2.10 | 2.12 | 2.29 | 4.54 | 1.41 | 1.11 | 1.93 | 1.34 | 1.46 | 10.21 | 1.96 | -0.03 | - | 1.68 | - | 1.93 | 1.77 | 1.37 |
EPS Growth | -0.87% | -52.86% | 48.64% | 90.99% | 18.65% | 238.81% | -3.39% | -89.13% | -1.61% | - | - | 509.23% | - | - | - | 22.31% | - | -16.81% | 172.33% | 3.01% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Innovative Medicine Innovative Medicine Growth | 16,384 | 15,426 | 15,763 | 15,563 | 15,202 | 13,873 | 14,332 | 14,580 | 14,490 | 13,562 | 13,722 | 13,893 | 13,731 | 13,413 | 13,163 | 13,214 | 13,317 | 12,869 | 14,217 | 12,882 |
MedTech MedTech Growth | 8,926 | 8,636 | 8,801 | 8,430 | 8,541 | 8,020 | 8,188 | 7,891 | 7,957 | 7,821 | 7,673 | 7,458 | 7,788 | 7,481 | 6,776 | 6,782 | 6,898 | 6,971 | 6,859 | 6,644 |
Revenue (Total) Revenue (Total) Growth | - | - | 24,564 | 23,993 | 23,743 | 21,893 | 22,520 | 22,471 | 22,447 | 21,383 | 21,395 | 21,351 | 21,519 | 20,894 | 23,706 | 19,996 | 24,020 | 23,426 | 24,804 | 23,338 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 28, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Cash & Investments Cash & Investments Growth | 20,758 | 22,051 | 20,102 | 18,562 | 18,880 | 38,781 | 24,522 | 20,297 | 25,475 | 26,218 | 22,927 | 23,511 | 28,505 | 24,613 | 22,281 | 34,079 | 32,568 | 30,388 | 31,608 | 32,868 |
Total Debt Total Debt Growth | 49,036 | 54,987 | 49,333 | 45,795 | 50,761 | 52,252 | 37,834 | 35,751 | 41,491 | 33,632 | 30,432 | 29,921 | 45,602 | 52,907 | 40,742 | 32,027 | 32,597 | 33,148 | 34,751 | 33,928 |
Net Cash (Debt) Net Cash Growth | -28,278 | -32,936 | -29,231 | -27,233 | -31,881 | -13,471 | -13,312 | -15,454 | -16,016 | -7,414 | -7,505 | -6,410 | -17,097 | -28,294 | -18,461 | 2,052 | -29 | -2,760 | -3,143 | -1,060 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11.59 | -13.47 | -11.98 | -11.21 | -13.18 | -5.56 | -5.48 | -6.37 | -6.61 | -3.05 | -2.71 | -2.51 | -6.51 | -10.86 | - | 0.77 | - | -1.04 | -1.18 | -0.40 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 28, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8,616 | 2,514 | 7,309 | 9,169 | 3,878 | 4,174 | 6,983 | 7,993 | 5,633 | 3,657 | 7,863 | - | 4,182 | 3,257 | - | 6,284 | - | 3,979 | 5,732 | 8,290 |
Capital Expenditures CapEx Growth | -1,321 | -1,049 | -1,837 | -1,157 | -1,043 | -795 | -1,612 | -1,029 | -976 | -807 | -1,427 | - | -1,124 | -863 | - | -952 | - | -607 | -1,415 | -747 |
Free Cash Flow Free Cash Flow Growth | 7,295 | 1,465 | 5,472 | 8,012 | 2,835 | 3,379 | 5,371 | 6,964 | 4,657 | 2,850 | 6,436 | - | 3,058 | 2,394 | - | 5,332 | - | 3,372 | 4,317 | 7,543 |
Free Cash Flow Growth | 157.32% | -56.64% | 1.88% | 15.05% | -39.12% | 18.56% | -16.55% | - | 52.29% | 19.05% | - | - | - | -29.00% | - | -29.31% | - | -0.74% | -38.50% | -1.35% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 28, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Gross Margin | 68.33% | 66.40% | 68.20% | 69.61% | 67.94% | 66.43% | 69.33% | 69.93% | 69.41% | 69.58% | 69.55% | 70.12% | 69.97% | 68.95% | - | 69.13% | - | 67.57% | 67.67% | 69.01% |
Operating Margin | 29.19% | 27.41% | 23.97% | 30.20% | 28.90% | 28.95% | 18.15% | 24.52% | 29.02% | 29.51% | 22.60% | 29.89% | 29.36% | 30.63% | - | 28.26% | - | 28.72% | 20.40% | 29.29% |
Pretax Margin | 26.66% | 24.89% | 20.22% | 31.23% | 27.34% | 62.26% | 17.26% | 14.85% | 25.61% | 17.37% | 22.56% | 24.43% | 29.30% | -6.16% | - | 25.87% | - | 25.02% | 19.50% | 16.49% |
Profit Margin | 21.87% | 21.76% | 20.83% | 21.47% | 23.32% | 50.24% | 15.24% | 11.99% | 20.88% | 15.22% | 18.93% | 121.91% | 23.90% | -0.33% | - | 22.29% | - | 21.98% | 19.09% | 15.71% |
FCF Margin | 28.82% | 6.09% | 22.28% | 33.39% | 11.94% | 15.43% | 23.85% | 30.99% | 20.75% | 13.33% | 30.08% | - | 14.21% | 11.46% | - | 26.66% | - | 14.39% | 17.40% | 32.32% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 28, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.340 | 1.300 | 1.300 | 1.300 | 1.300 | 1.240 | 1.240 | 1.240 | 1.240 | 1.190 | 1.190 | 1.190 | 1.190 | 1.130 | - | 1.130 | - | 1.060 | 1.060 | 1.060 |
Dividend Per Share Growth | 3.08% | 4.84% | 4.84% | 4.84% | 4.84% | 4.20% | 4.20% | 4.20% | 4.20% | 5.31% | - | 5.31% | - | 6.60% | - | 6.60% | - | 4.95% | 4.95% | 4.95% |
Dividend Yield | 2.07% | 2.19% | 2.51% | 2.89% | 3.39% | 3.15% | 3.55% | 3.18% | 3.50% | 3.23% | 3.24% | 2.45% | 2.29% | 1.61% | - | 2.23% | - | 2.70% | 2.80% | 2.97% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 28, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
PE Ratio | 29.14 | 27.53 | 18.66 | 17.23 | 16.18 | 18.09 | 24.83 | 26.46 | 9.25 | 9.91 | 10.73 | 13.01 | 45.12 | - | - | 29.95 | - | 23.63 | 21.57 | 23.63 |
Forward PE | 21.57 | 20.82 | 18.78 | 16.49 | 14.45 | 15.49 | 14.42 | 16.29 | 13.90 | 14.85 | 15.05 | 14.98 | 15.63 | 14.74 | 17.49 | 16.07 | 17.52 | 16.93 | 16.98 | 16.36 |
P/FCF Ratio | 27.56 | 32.57 | 25.40 | 22.09 | 19.77 | 19.37 | 17.60 | 18.58 | 25.23 | 30.88 | 31.74 | - | 39.89 | 52.43 | - | 32.99 | - | 23.75 | 22.79 | 18.81 |
PS Ratio | 6.26 | 6.01 | 5.31 | 4.70 | 4.05 | 4.42 | 3.93 | 4.43 | 4.06 | 4.45 | 4.43 | 6.35 | 6.89 | 9.91 | - | 6.30 | - | 4.94 | 4.80 | 4.62 |